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ABSTRACT
Earlier genetic and structural prediction analyses revealed that the packaging determinants of Mason Pfizer monkey virus (MPMV)
include two discontinuous core regions at the 5′ end of its genomic RNA. RNA secondary structure predictions suggested that
these packaging determinants fold into several stem–loops (SLs). To experimentally validate this structural model, we
employed selective 2′ hydroxyl acylation analyzed by primer extension (SHAPE), which examines the flexibility of the RNA
backbone at each nucleotide position. Our SHAPE data validated several predicted structural motifs, including U5/Gag long-
range interactions (LRIs), a stretch of single-stranded purine (ssPurine)-rich region, and a distinctive G-C-rich palindromic (pal)
SL. Minimum free-energy structure predictions, phylogenetic, and in silico modeling analyses of different MPMV strains
revealed that the U5 and gag sequences involved in the LRIs differ minimally within strains and maintain a very high degree of
complementarity. Since the pal SL forms a helix loop containing a canonical “GC” dyad, it may act as a RNA dimerization
initiation site (DIS), enabling the virus to package two copies of its genome. Analyses of wild-type and pal mutant RNAs
revealed that disruption of pal sequence strongly affected RNA dimerization. However, when in vitro transcribed trans-
complementary pal mutants were incubated together showed RNA dimerization was restored authenticating that the pal loop
(5′-CGGCCG-3′) functions as DIS.
Keywords: Mason Pfizer monkey virus (MPMV); RNA dimerization; dimerization initiation site (DIS); RNA packaging signal;
long-range interaction (LRI)
INTRODUCTION
The “diploid” genome of retroviruses consists of two (usually
indistinguishable) strands of RNA that are noncovalently
linked as a “dimer” close to their 5′ end (for review, see
Paillart et al. 1996b, 2004; D’Souza and Summers 2005;
Lever 2007; Moore and Hu 2009; Johnson and Telesnitsky
2010; Lu et al. 2011a). The ubiquitous presence of such a
unique dimeric genome among retroviruses suggests that
dimerization plays a crucial role in the packaging of the geno-
mic RNA (gRNA), as well as in the subsequent steps of the vi-
ral life-cycle (for review, see Paillart et al. 2004; Russell et al.
2004; Moore and Hu 2009).
Over the years, we have learned that almost for all retrovi-
ruses, determinants of gRNA dimerization and packaging
map to ∼100 to 400 nucleotides (nt) at the 5′ end of the
gRNAs, which have been shown to assume stable secondary
structures (for review, see Paillart et al. 1996b; Johnson and
Telesnitsky 2010). The gRNA dimerization and packaging se-
quences are, for the most part, physically and genetically in-
distinguishable, and consistently, it has been suggested that
the retroviral gRNA packaging and dimerization processes
are interlinked (for review, see Paillart et al. 2004; D’Souza
and Summers 2005; Lever 2007; Johnson and Telesnitsky
2010; Lu et al. 2011a).
It is becoming increasingly clear that palindromic (pal)
sequences play a crucial role in gRNA dimerization: For hu-
man immunodeficiency type 1 and type 2 viruses (HIV-1 and
HIV-2), feline immunodeficiency virus (FIV), Moloney
murine leukemia virus (MoMuLV), and murine sarcoma
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gamma retroviruses (MuSV), it has been shown that the dime-
rization process is initiated by a pal sequence in its structural
context (pal stem–loop), which is called the dimerization ini-
tiation site (DIS) (for review, see Paillart et al. 1996b, 2004;
Russell et al. 2004; D’Souza and Summers 2005; Lever 2007;
Moore and Hu 2009; Johnson and Telesnitsky 2010; Lu
et al. 2011a). The pal of different retroviruses has been shown
to contain a canonical “GC” dyad (for review, see Hussein
et al. 2010). The pal in the DIS loop of one gRNA has been
shown to interact with the complementary sequence in the
DIS loop on the second gRNA, resulting in the “kissing
loop” interaction (Paillart et al. 1994, 1996a, 1997; Clever
et al. 1996; Haddrick et al. 1996; Lodmell et al. 2000, 2001).
Due to its central role in gRNA dimerization process that
has been shown to be important for gRNA packaging and
the continuity of viral life cycle, DIS has been an attractive
target for antiretroviral drugs specifically aminoglycosides
(Ennifar et al. 2003, 2006). The formation of “kissing loop”
complex is likely to be further stabilized by the long-range in-
teractions (LRIs) between the 5′ end (R/U5) and 3′ end (gag)
sequences of the retroviral packaging signal RNA (for review,
see Paillart et al. 1996b). In addition, it has also been pro-
posed that in some retroviruses “kissing loop” interactions
and dimer linkage maturation process lead to conformational
changes exposing single-stranded nucleocapsid (NC) bind-
ing motifs, facilitating Gag binding during recruitment of
the gRNA for packaging (for review, see D’Souza and
Summers 2005; Johnson and Telesnitsky 2010). Along the
same lines, a recent study has shown that in addition to
the conventional dimerization/packaging sequences, HIV-1
gRNA packaging is enhanced by a cis-acting RNA element
(the gRNA packaging enhancer or GRPE) overlapping the
Gag/Pol ribosomal frameshift signal (Chamanian et al. 2013).
Despite the fact that gRNA dimerization and packaging
processes are universally present in all retroviruses, there is
no sequence conservation between the dimerization and
packaging determinants among different retroviruses. Over
the years, it is becoming increasingly clear that retroviral
gRNA dimerization and packaging are reliant on highly
ordered RNA structural motifs of the 5′ end RNA region
(for review, see D’Souza and Summers 2005; Lever 2007;
Johnson and Telesnitsky 2010; Lu et al. 2011a). Therefore,
it is not surprising that a number of recent cross- and copack-
aging studies have elucidated that the specificity of retroviral
gRNA packaging can be manipulated by substituting di-
merization and packaging sequences at the 5′ end of genome
from genetically distinct retroviruses (Al Dhaheri et al. 2009;
Al Shamsi et al. 2011). This has further been substantiated
by the fact that heterodimers involving RNAs from two
divergent retroviruses can also be packaged (Motomura
et al. 2008; Moore et al. 2009; for review, see Johnson and
Telesnitsky 2010).
A stretch of 5′ end sequences of the prototype β-retrovirus
Mason-Pfizer monkey virus (MPMV), which causes an im-
munodeficiency disease in newborn rhesus monkey, has
been shown to be involved in RNA packaging (Vile et al.
1992; Harrison et al. 1995; Guesdon et al. 2001). Employing
a combination of genetic and structural prediction analyses,
we have recently shown that MPMV packaging determinants
comprise two discontinuous core regions (“A” and “B”) with-
in the 5′ untranslated region (UTR) (Schmidt et al. 2003;
Jaballah et al. 2010). In addition to these two regions in the
UTR, a stretch of ∼120 nt of gag have also been shown to be
needed for optimal MPMV RNA packaging (Schmidt et al.
2003; Jaballah et al. 2010). Based on these mutational studies
and structural prediction analyses, a minimal free energy
RNA secondary structure model has been proposed for the
5′ end (388 nt starting from R) of MPMV gRNA (Fig. 1A;
Jaballah et al. 2010). This model suggested that the packag-
ing determinants fold into several stable stem–loop (SL)
structures and also revealed a 14-nt GC-rich pal sequence
(5′-UCGCCGGCCGGCGA-3′) that folds into a hairpin
with a canonical “GC” dyad in the loop, a 16-nt stretch of
single-stranded purine (ssPurine)–rich region (8 nt of this
ssPurine-rich region is duplicated as a base-paired sequence
in an adjacent region), and LRIs between U5 and gag se-
quences (Jaballah et al. 2010). The 14-nt pal has been pro-
posed to play a role in the initiation of gRNA dimerization
(Jaballah et al. 2010). The ssPurine-rich region (or its repeat
in region “B”when predicted to refold as the ssPurine-rich re-
gion) has been shown to be essential for RNA packaging, pos-
sibly functioning as a potential NC binding site. Two LRIs
between U5 and gag sequences could potentially play a role
in MPMV RNA packaging by maintaining the overall RNA
secondary structure as has recently been shown in the case
of FIV (Kenyon et al. 2008, 2011; Rizvi et al. 2010). Even
though the deletion analysis of 5′ end of MPMV gRNA pro-
vides a plausible explanation for the discontinuous nature
of MPMV packaging signals, the existence of the different
structural motifs of the predicted RNA secondary structure
of this region has not been validated experimentally.
RESULTS AND DISCUSSION
To validate the predicted structure (Jaballah et al. 2010) and
to generate a more precise structural model of the MPMV
gRNA packaging signals, we employed selective 2′ hydroxyl
acylation analyzed by primer extension (SHAPE), which ex-
amines the flexibility of the RNA backbone at each nucleotide
position (Merino et al. 2005; Mortimer and Weeks 2007,
2009). SHAPE reagents target and modify the ribose moiety
of all 4 nt in single-stranded regions of a folded RNA mole-
cule, whereas the nucleotides that are base-paired or architec-
turally constrained do not react or show reduced reactivity.
SHAPE data validated the major structural motifs
predicted in the 5′ end of MPMV gRNA
Our SHAPE data validated the overall predicted structure
(Jaballah et al. 2010) of the MPMV packaging signal RNA.
MPMV RNA dimerization
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Figure 1A shows the unconstrained predicted structure,
whereas Figure 1B shows the SHAPE-validatedMPMV struc-
ture. An average of SHAPE reactivities numerical data for each
nucleotide that were drawn from two to four experiments
were applied as pseudo energy constraints in RNAstructure
(Reuter andMathews 2010; Bellaousov et al. 2013). As shown
in Figure 1B, the SHAPE data robustly corroborated the free-
energy minimized predicted structure of the MPMV packag-
ing signal RNA presented in Figure 1A. Briefly, the SHAPE-
validated model displayed major structural components, in-
cluding pal SL, ssPurine-rich region, U5-Gag LRIs, SLs 1-3,
and Gag SLs 1-2, in extensive conformity with the predicted
structure. Consistent with the predicted structure, all the
loops and bulges containing unpaired nucleotides showed
SHAPE reactivity. A few base-paired nucleotides located at
the ends of a helix or near a bulge or a loop also showed reac-
tivity (e.g., nt 22, 25, and 26). Despite such a high conformity
between the predicted and the SHAPE-validated structure
models, some noticeable differences could be observed.
First, SHAPE data indicated that the actual apical loop of
SL2 is larger than predicted by Mfold (Fig. 1A,B). Second,
this loop is shifted by 2 nt, inducing different base-pairing
in the upper part of SL2, including the primer binding site
(PBS). Third, a small SLwas observed in the SHAPE-validated
structure at the base of Gag SL2, which was not present in the
predicted structure model of the MPMV packaging signal
RNA. Finally, even though the same pal SL is present in the
two structures, it is interesting to observe that the nucleotides
in the loop, which contains the “GC” dyad, displayed weak
or no reactivity, suggesting that these nucleotides are indeed
base-paired. One possibility is that these nucleotides may be
base-paired with the same sequence on the other gRNA,
which is consistent with the hypothesis that the pal SL might
function as the DIS of MPMV gRNA (Jaballah et al. 2010).
A very distinguishing feature of the predicted and the
SHAPE-validated structure are the two LRIs (LRI-I and
LRI-II) involving sequences from U5 and first 70 nt of gag
(Fig. 1), which have been shown to be important in
MPMV RNA packaging (Schmidt et al. 2003; Jaballah et al.
2010). Except for canonical base pairs at both ends of LRI-
I, and wobble base pairs in both LRIs, all nucleotides (except
U62) in the complementary sequences of the LRIs were non-
reactive to SHAPE reagent and, therefore, were base-paired as
initially predicted (Jaballah et al. 2010). U62 is highly reactive
to the SHAPE reagent and forms a bulge in LRI-II that was
not predicted by Mfold.
FIGURE 1. Minimal free-energy and SHAPE (selective 2′ hydroxyl acylation analyzed by primer extension)-validated models of the MPMV pack-
aging signal RNA. The region used for analysis byMfold and SHAPE included sequences fromR up to 120 nt of gag. (A) MPMV packaging signal RNA
secondary structure predicted earlier (Jaballah et al. 2010) using Mfold (Mathews et al. 1999; Zuker 2003). Sequences in orange, green, red, and blue
represent the primer binding site (PBS), regions “A” and “B” (that have been shown to be important in gRNA packaging), and pal sequences, respec-
tively. Boxed areas in purple show the predicted LRIs between U5 and gag. (B) SHAPE-constrained RNAstructure (Reuter and Mathews 2010) model
of MPMV packaging signal. Nucleotides are color annotated as per the SHAPE reactivities key. SD indicates splice donor.
Aktar et al.
1650 RNA, Vol. 19, No. 12
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
Sequences in pal SL augments MPMV gRNA
dimerization by functioning as DIS
Earlier studies have shown that deletion of the 14-nt pal SL
severely compromised MPMV gRNA packaging (Schmidt
et al. 2003; Jaballah et al. 2010). However, these studies did
not study the impact of these mutations on gRNA dimeriza-
tion. The conservation of the pal sequence in different strains
of MPMV (Fig. 4F) and the fact that it forms a hairpin with a
“GC” dyad in the loop (Fig. 1) makes it a credible candidate
to function as MPMV gRNADIS. Therefore, we introduced a
series of mutations in the pal sequence (Fig. 2A) and per-
formed in vitro dimerization assays using in vitro transcribed
RNAs. The mutant RCR002 contains the complete deletion
of the pal sequence. In order to ascertain whether preserva-
tion of the hairpin structure is sufficient to initiate dimeriza-
tion, mutant RCR003 was created in which the central 4 nt of
the loop were substituted with a stable tetra loop sequence. In
order to determine if it is the primary sequence or pal nature
of the pal sequence that is required for MPMV gRNA dime-
rization, another mutant (RCR004) was constructed that
contains the substitution of the central 6 nt of MPMV pal se-
quence with that of HIV-1 pal sequence. Before introducing
these mutations, Mfold was used to predict the structure of
the mutants in the monomer form to support the premise
of our experimental hypothesis.
The data obtained from three independent in vitro dimeri-
zation experiments using wild-type and pal mutant RNAs are
summarized in Figure 2, B and C. In vitro transcribed wild-
type RNA showed ∼87% and 65% dimerization in TBM
(50mMTris base, 45mM boric acid, 0.1 mMMgCl2; electro-
phoresis at 4°C) and TB (50 mM Tris base, 45 mM boric
acid; electrophoresis at room temperature) gels, respectively
(Fig. 2B). These wild-type (RCR001) values were considered
as references for calculating the relative dimerization effici-
ency (RDE) of the mutants (Fig. 2C). The pal deletion and
FIGURE 2. Sequences in pal SL augments MPMV gRNA dimerization by functioning as DIS. (A) Table showing the 6-nt wild-type pal sequence (in
red) and the different mutations introduced (in blue). (B) Gel shift assays of the MPMV wild-type and pal mutants. The upper panel shows native 1%
TBM (50 mM Tris base, 45 mM boric acid, 0.1 mMMgCl2) gel run at 4°C, and the lower panel shows semi-native 1% TB (50 mM Tris base, 45 mM
boric acid) gel run at room temperature. M indicates monomer lane or monomer conformer; D, dimer lane or dimer conformer for each sample. (C)
Relative dimerization of the MPMV wild-type and pal mutants RNAs. Following the gel shift assays, dimerization abilities of the RNAs in each lane
were calculated, and the dimerization data were then represented as relative to the wild-type dimerization. (D) Structure prediction of the MPMV
wild-type RNA +1–388 dimer structure. The site of interaction between the two gRNAs involving the pal sequence is enlarged for the sake of clarity.
The central 6 nt of the pal are shown in red.
MPMV RNA dimerization
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substitution mutants showed significant degrees of reduction
in their abilities to dimerize (RDEs 0.19–0.25 in both semi-
native and native conditions; fourfold to 5.27-fold reduction;
P = 0.002–0.02) (Fig. 2C) compared with the wild-type.
Mutants RCR002 and RCR003 showed that not only the pal
SL structure but also the nature of the pal sequence are impor-
tant for MPMV gRNA dimerization. The results obtained
with mutant RCR004 are more difficult to explain. The
Mfold structural model of RCR004 predicted the formation
of a SL similar to MPMV pal SL (data not shown), and there-
fore, thismutantwas expected to restore dimerization towild-
type levels, in contrast with our observation (Fig. 2B,C). In
the case of HIV-1, the 5′-GCGCGC-3′ pal is flanked by three
purines residues that are crucial for the stability of the RNA
dimer (Paillart et al. 1997). Therefore, the inability of
RCR004 to restore dimerization could in part be attributed
to the absence of flanking purines similar to HIV-1 pal in
its native genomic context.
Next we wanted to correlate the results of in vitro dimeri-
zation to the SHAPE-validated structural model and estab-
lish the structure-function relationships, if any, of MPMV
pal SL during gRNA dimerization. Therefore, we folded
two molecules of the wild-type 5′ end MPMV gRNA using
RNAstructure to predict the folding pattern of a dimer.
Folding prediction of the wild-type homodimer showed an
overall preservation of the RNA secondary structure of the
monomer, with a conformational change in the pal SL, which
was predicted to interact and base-pair with the pal sequence
on the second MPMV gRNA sequence (Fig. 2D). Thus, this
structure prediction points toward the importance of the
pal SL sequence in MPMV gRNA dimerization, consistent
with our RNA dimerization assay and with our SHAPE
data, which showed that the loop of the pal hairpin is only
moderately reactive. Furthermore in the homodimer struc-
ture, the ssPurine-rich region were predicted to form a helix
loop structural motif (Fig. 2D; Supplemental Fig. 1), possibly
making it more accessible for possible interaction with NC
protein as has earlier been suggested (Jaballah et al. 2010).
In sharp contrast, the homodimer structural predictions
of mutants RCR002 and RCR003 suggested that these mu-
tants could dimerize using another 6-nt pal sequence (5′-
GGCGCC-3′) within the PBS (data not shown). This PBS-
mediated homodimerization results in the overall destabiliza-
tion of the RNA secondary structure and is consistent with
our in vitro dimerization results. Taken together, our in vitro
dimerization and structure prediction results suggest that the
14-nt GC-rich MPMV pal SL is important in mediating
gRNA dimerization by functioning as a DIS.
In vitro heterodimerization can be mediated by
trans-complementary sequences on two RNAs
To confirm that the central 6 nt of the pal, indeed, constitute
the point of contact between two gRNAs to initiate the process
of dimerization, we created two trans-complementary mu-
tants maintaining the central “GC” dyads (RCR005 and
RCR006) (Fig. 3A). When incubated separately, the RCR005
and RCR006 mutant RNAs formed significant amounts of
dimer in TBM, even though dimerization was reduced com-
pared with wild-type RNA (RDEs; 0.69–0.70; 1.43- to 1.45-
fold reduction; P = 0.029–0.047) (Fig. 3B,C). However, the
ability of these mutant RNAs to dimerize was severely com-
promised in semi-native condition (RDEs; 0.14 and 0.09 for
RCR005 and RCR006, respectively; 7.14- to 11.11-fold reduc-
tion; P = 0.062–0.042) (Fig. 3B, lower panel, C). In contrast,
when incubated together, these trans-complementarymutant
RNAs dimerized to wild-type level, in both native and semi-
native conditions (RDEs 0.88–1.09) (Fig. 3B, last lane, C).
These results prove that an intermolecular interaction me-
diated by the central 6 nt of pal is required for the formation
of a stable RNA dimer. In addition, they reveal the existence
of a second intermolecular interaction, which allows forma-
tion of unstable dimers. Consistent with this interpretation,
the unstable homodimers formed by RCR005 and RCR006
RNAs migrated slightly more slowly than the heterodimer
or the wild-type RNA homodimer (Fig. 3B, top panel), con-
firming that they formed different RNA dimers.
In an attempt to identify the residual intermolecular inter-
action in mutants RNAs, we employed RNAstructure to pre-
dict the RCR005 and RCR006 homodimer and heterodimer
structures. Structure predictions suggested that the mutant
RNAs RCR005 and RCR006 homodimerized via an alternate
6-nt pal sequence within the PBS (Fig. 3D,E; Supplemental
Fig. 1B,C). As a consequence, SL2, which is relatively long
in the wild-type homodimer and in the RCR005/RCR006
heterodimer, was predicted to be shortened due to PBS-
mediated intermolecular interactions; however, its apical
loop was maintained (Fig. 3D,E; Supplemental Fig. 1B,C).
In the predicted heterodimer structure of mutants RCR005
and RCR006, the two RNAs interact via the substituted
trans-complementary sequences (Fig. 3F,G; Supplemental
Fig. 1D) as expected and as supported by our experimental
data (Fig. 3B and C). As a result, the secondary structures
of the wild-type RNA homodimer and of the RCR005/
RCR006 heterodimer are identical (Figs. 2D, 3G; Supplemen-
tal Fig. 1). RNAstructure predictions of the RCR005 and
RCR006 homodimers and heterodimer illustrate that not
only does the interaction between these trans-complementa-
ry sequences result in heterodimerization, but also that such
an interaction leads to conformational changes in the struc-
ture allowing more extensive base-pairing between com-
plementary sequences throughout the genome (Fig. 3G;
Supplemental Fig. 1).
In summary, our systematic mutational analyses directed
toward ascertaining the functional significance of pal SL
demonstrated that mutations targeted toward disrupting
the formation of the 6-nt pal loop diminished RNA dimeri-
zation (Figs. 2, 3). This could be attributed to the RNA fold-
ing pattern rather than the primary sequence of the pal loop
Aktar et al.
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since mutants containing trans-complementary sequences
in this loop were not only able to heterodimerize at wild-
type levels but also able to re-establish the overall wild-type
RNA secondary structure (Figs. 2D, 3G; Supplemental Fig.
1). These results strongly suggest that the pal loop is involved
in “kissing loop” interactions between two MPMV gRNAs in
order to initiate gRNA dimerization and thus functions as
DIS. These observations corroborate with an earlier genetic
analysis that showed no effect on RNA packaging when the
MPMV native pal sequence was accidentally substituted
with a different pal sequence (Mustafa et al. 2004).
The SHAPE-validated secondary structural model
is supported by sequence conservation between
different MPMV isolates
In order to examine the conservation of different structural
motifs within the MPMV packaging signal RNA, sequences
from different strains of MPMV were used to predict the
RNA secondary structure of this region. Mfold predictions
of the sequences from different MPMV strains consistently
revealed the ability to form both LRIs involving sequences
from U5 and gag (Fig. 4A–E). A sequence alignment of this
region for these MPMV isolates was generated using
ClustalW and revealed a high degree of conservation of the
sequences in the two U5-Gag LRIs. The U5 and gag sequenc-
es forming these LRIs slightly differ but maintain a very high
degree of complementarity (Fig. 4A–F).
Based on the RNA free-energy minimized model predicted
earlier and validated by SHAPE (Fig. 1) in addition to the
phylogenetic and in silico modeling analyses presented here
(Fig. 4), it is reasonable to hypothesize that such LRIs be-
tween U5 and gag sequences are likely to exist in vivo and
have a functional role in MPMV life cycle. Consistent with
this, deletion of the gag sequences involved in U5-Gag LRI-
II while maintaining the gag sequences that are involved in
U5-Gag LRI-I severely diminished MPMV transfer vector
RNA packaging ability (Schmidt et al. 2003). On the other
hand, inclusion of first 100 nt of gag sequences that would
maintain both U5-Gag LRIs in the transfer vector RNA re-
stored packaging efficiency to the wild-type level (Schmidt
et al. 2003). These results suggest that LRI-I and LRI-II
FIGURE 3. In vitro heterodimerization can be mediated by trans-complementary sequences on two RNAs. (A) Table showing the 6-nt wild-type pal
sequence (in red) and the two complementary substitution mutations (in blue). (B) In vitro dimerization assay of the MPMV wild-type and pal mu-
tants. The upper panel shows native 1% TBM gel run at 4°C, and the lower panel shows semi-native 1% TB gel run at room temperature. M indicates
monomer lane or monomer conformer; D, dimer lane or dimer conformer for each sample. (C) Relative dimerization of the complementary mutants
to the wild-type RNAs. Dimerization abilities of the RNAs in each lane were calculated, and the dimerization data were represented as relative to the
wild-type dimerization. (D,E) Structure predictions of the mutant RCR005 (D) and RCR006 (E) MPMV RNAs +1–388 using RNAstructure. (F)
Schematic representation of the expected point of heterodimerization between RCR005 and RCR006MPMV RNAs. (G) Predicted heterodimer struc-
ture of RCR005 and RCR006 RNAs.
MPMV RNA dimerization
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play an important architectural role in stabilizing the RNA
secondary structure of the 5′-UTR sequences required for
MPMV gRNA packaging (Schmidt et al. 2003; Jaballah
et al. 2010). Such a scenario could be comparable to that ob-
served in other retroviruses (HIV-1, HIV-2, and FIV) where
interactions between the R/U5 regions and the start of gag
sequences have been proposed to stabilize the overall RNA
secondary structure essential for gRNA dimerization and
packaging (Paillart et al. 2002; Kenyon et al. 2008, 2011;
Song et al. 2008; Rizvi et al. 2010; Lu et al. 2011b).
Between SL2 and SL3 of our SHAPE-validated RNA struc-
ture is a very distinctive pal SL, which has earlier been shown
to be required for optimal packaging of MPMV gRNA
(Jaballah et al. 2010). The current study revealed that the cen-
tral 6 nt of this pal (5′-CGGCCG-3′) functions as DIS, thus
probably facilitating the encapsidation of the dimeric ge-
nome. Sequence alignment of five different strains of
MPMV revealed that the 6-nt central pal is conserved in all
but one strain (Fig. 4F). In one strain (SRV1), the last G is sub-
stituted with a C residue, but this strain still contains a 6-nt
GC-rich pal (5′-GCCGGC-3′) shifted by 2 nt compared
with the other strains (Fig. 4F), supporting a functional role
for this pal. Mfold analysis of these strains further revealed
that in three strains (MPMV 6/A, SRV1, and SRV2), the pal
sequence fold into a SL (Fig. 4A–C). In the case of SRV4,
the pal sequence is base-paired; whereas in the case of
SRV5, the pal sequence forms two small
bulges (Fig. 4D,E). Similar conservation
of a DIS comprising a pal sequence has
been reported in several retroviruses, in-
cluding HIV-1, HIV-2, SIV, and FIV
(Paillart et al. 2002; Russell et al. 2004;
Lever 2007; Kenyon et al. 2008, 2011).
In a number of retroviruses, sequences
augmenting RNAdimerization and pack-
aging have been shown to be intermin-
gled (Lanchy et al. 2003; Paillart et al.
2004; Russell et al. 2004; Lanchy and
Lodmell 2007; Lever 2007), which is in
agreement with the deletion of MPMV
pal SL resulting in ablation of RNA pack-
aging (Jaballah et al. 2010).
Earlier studies have identified a prom-
inent stretch of ssPurine-rich region
between pal SL and SL3, and a partial
base-paired repeat sequence of the
ssPurine-rich region was observed in the
adjacent region (“B”) (Fig. 1A; Jaballah
et al. 2010). Sequence alignment revealed
that out of the 16 nt within the ssPurine-
rich region, 10 nt are conserved among all
the analyzedMPMV strains (Fig. 4F). The
validation of the ssPurine-rich region and
its based-paired repeat structural motifs
by SHAPE (Fig. 1B) in concurrence with
sequence alignment (Fig. 4F) and earlier mutational and
structure prediction analyses (Jaballah et al. 2010) further
emphasize the importance of the ssPurine-rich region in
MPMV life cycle.
SL1, SL2, and SL3 are present in spliced as well as gRNAs
To establish the structure-function relationship of structural
motifs (especially of those present upstream of the major
splice donor [mSD] site) and to address how some of them
may help the MPMV packaging machinery in differentiating
between genomic and spliced RNA, we predicted the struc-
ture of the 5′ region of the MPMV env spliced RNA (includ-
ing 251 nt upstream of themSD and 138 nt downstream from
env splice acceptor site). Mfold structural predictions re-
vealed that SL1, SL2, and SL3 are present in both MPMV 5′
end genomic and env spliced RNAs (Supplemental Fig. 2).
SL1, SL2, and SL3 were also predicted to be present in the
shorter MPMV leader RNA that was truncated at the mSD
(+1–251; data not shown). The function of SL1 in the retro-
viral life cycle has not yet been established; however, Mfold
predictions (Fig. 4A–E) and sequence alignments (Fig. 4F)
of five different strains of MPMV showed that this motif is
conserved at the sequence and structural levels.
SL2 is a rather long and stable structure from which PBS
protrudes (Fig. 1A,B). It is present in the SHAPE-validated
FIGURE 4. Mfold structural predictions (A–E) and ClustalW (F) sequence alignment of the 5′
end genomes of different MPMV strains. (A–E) The U5/Gag LRIs and the pal sequence are high-
lighted by red and green boxes, respectively. (F) The aligned sequences pertaining to major struc-
tural motifs are highlighted by different colors and boxed. The accession nos. for MPMV6/A,
SRV1, SRV2, SRV4, and SRV5 are M12349.1 (Sonigo et al. 1986), M11841.1 (Power et al.
1986), AF126467.1 (Marracci et al. 1995), FJ979638.1 (Zao et al. 2010), and AB611707.1
(Takano et al. 2013), respectively.
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structure of the gRNA (Fig. 1B) and is predicted to exist in the
env spliced RNA (Supplemental Fig. 2). In silico analysis re-
vealed a high degree of conservation in the sequences form-
ing SL2 (Fig. 4F), which was predicted to fold in three out of
the five MPMV strains (MPMV 6/A, SRV4, and SRV5) (Fig.
4A–E). In addition, SL2 has been shown to include sequences
that constitute part of a bipartite packaging signal (Jaballah
et al. 2010). All together, these data points toward the impor-
tance of the overall RNA secondary structure of SL2 in the
MPMV life cycle (Schmidt et al. 2003; Jaballah et al. 2010).
Immediately downstream from the ssPurine-rich region is
SL3, which like SL1 and SL2 was consistently predicted to
fold in both genomic and spliced RNAs (Supplemental Fig.
2). Mfold predictions of differentMPMV strains demonstrat-
ed that SL3 is formed in all except for one strain (Fig. 4A–E),
and its sequences are fairly conserved among different strains
(Fig. 4F). However, deletion of the majority of the sequences
that are involved in base-pairing of SL3 did not affect RNA
packaging (Jaballah et al. 2010), suggesting that it might
play a role in MPMV life cycle that has not yet been
established.
CONCLUDING REMARKS
Employing SHAPE, we validated the overall predicted struc-
ture of the MPMV packaging signal RNA (Fig. 1; Jaballah
et al. 2010). Briefly, MPMV packaging signal RNA comprised
five SL structures. SL1–SL3 includes sequences from R/U5
and UTR, whereas Gag SL1 and Gag SL2 employ sequences
exclusively from gag.
SL2 involves sequences from region “A,” whereas SL3 in
part comprises sequences from region “B”; both of these re-
gions have been shown earlier as major MPMV gRNA pack-
aging determinants (Schmidt et al. 2003; Jaballah et al. 2010).
Between SL2 and SL3 is a very distinctive pal SL followed by a
stretch of ssPurine-rich region, both of which have also been
shown to be required for optimal packaging of MPMV gRNA
(Jaballah et al. 2010). The overall structure is anchored by
two LRIs (Fig. 1A,B) involving sequences from U5 and the
first 70 nt of gag, which have been shown to be important
in MPMV RNA packaging (Schmidt et al. 2003; Jaballah
et al. 2010). Mfold predictions of different MPMV strains
consistently revealed the ability to form LRIs suggesting a
functional role for these LRIs (Fig. 4A–E).
Employing a systematic mutational approach, we showed
that the central 6 nt of the pal, which are exposed in the pal
SL loop play a crucial role in RNA dimerization by directly
interacting with a second gRNA molecule (Figs. 2, 3;
Supplemental Fig. 2). Thus, this sequence likely initiates
gRNA dimerization by forming a kissing loop complex.
Despite some sequence variability, allMMPV strainsmaintain
a 6-nt GC pal at this position, reinforcing its functional role.
The SHAPE-validated structural model, in vitro dimeriza-
tion analysis of pal mutant, and the homo- and heterodimer
structural models presented here coupled with earlier pub-
lished findings on MPMV RNA packaging signals offer im-
portant functional correlation between gRNA dimerization
and the packaging processes. These observations while broad-
ening the understanding of functional regions of MPMV
gRNA further suggest that MPMV may select a dimeric ge-
nome for packaging.
MATERIALS AND METHODS
MPMV RNA secondary structure analyses in silico
MPMV RNA (388 nt and 550 nt) secondary structure was predicted
using the Mfold server (Mathews et al. 1999; Zuker 2003) and vali-
dated by applying SHAPE reactivity data in the RNAstructure soft-
ware (version 5.3) (Reuter and Mathews 2010). The predicted RNA
secondary structures were redrawn with XRNA software. Sequences
from different strains of MPMV corresponding to packaging signal
RNA were employed to predict the RNA secondary structures of the
region using Mfold (Mathews et al. 1999; Zuker 2003). A sequence
alignment of the same region for these MPMV isolates was also gen-
erated using ClustalW to look for the conservation of sequences in
different structural motifs. MPMV nucleotide positions refer to
GenBank accession no. M12349 (Sonigo et al. 1986).
Plasmids used for in vitro transcription (wild-type
and pal mutants)
In order to in vitro transcribe the wild-type MPMV genomic se-
quences for SHAPE analysis, SJ2 subgenomic transfer vector (de-
scribed previously by Jaballah et al. 2010) containing the cis-acting
sequences needed for genome replication was used as a template
for generating the clone RCR001 by PCR. Primers used for PCR am-
plification included sense (S) primer OTR1004 (5′-CCCAAG
CTTAATACGACTCACTATAGGGCCACCATTAAATGAGACTTG
ATC-3′) containing the HindIII restriction site and the T7 RNA po-
lymerase promoter sequence (HindIII site is shown in italics, where-
as the T7 promoter sequence is underlined) and the anti-sense (AS)
primer OTR 1005 (5′-AAACCCGGGTTCTTTCTTATCTATCAA
TTC-3′) containing XmaI/SmaI site (shown in italics). The resulting
PCR product was cleaved at the HindIII and XmaI sites (artificially
created on either ends of the MPMV sequence) and ligated to a
PUC-based cloning vector (pIC19R) (Marsh et al. 1984), which
was previously cleaved with the same restriction enzymes generating
wild-type plasmid pRCR001. pRCR001 contains nucleotides +1 to
550 (+1 corresponds to the first nucleotide of the R region of the
gRNA) under the control of a T7 promoter for in vitro transcription
of the RNA.
To study the effects of the pal sequence (5′-TCGCCGGCCGGCG
A-3′) on in vitro dimerization, a series of mutations were introduced
in the pal sequence. Briefly, these mutations were incorporated
through splice overlap extension (SOE) PCR according to the meth-
od described previously (Gibbs et al. 1994; Jaballah et al. 2010; Rizvi
et al. 2010) using MPMV subgenomic vector SJ2 as the template re-
quiring two separate amplifications in round-one PCR. In brief,
both S and AS primers that were used in two separate reactions of
round-one PCRs were designed in a fashion that the resulting prod-
ucts from the two reactions have overlapping complementary se-
quences. The overlapping complementary sequences allowed the
MPMV RNA dimerization
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two products to anneal during the second round of amplification
with the outer S and AS primers, resulting in a final product contain-
ing the desired deletion mutation. The mutations introduced in-
cluded deletion of the complete 14-nt pal SL sequence (5′-TCG
CCGGCCGGCGA-3′) using S primer OTR 897 (5′-CACTTTT
AAACGCGTCGTCTTCCTCAC G-3′) and AS primer OTR 898A
(5′-CGCGTTTAAAAGTGAAAGTAAACTCTCTTG-3′), resulting in
RCR002 (Fig. 2A). Substitution of the 4-nt pal loop 5′-GGCC-3′
with GTAA to generate a stable tetra loop was created using S primer
OTR 996 (5′-GTAAGGCGATTAAAAGTGAAAGTAAACTC-3′)
and AS primer OTR 997 (5′-CACTTTTAATAGCCTTACGGCG
AACGCGTCGTC-3′), generating mutant RCR003 (Fig. 2A). A mu-
tant containing substitution of the 6-nt pal with HIV-1 pal sequence
(5′-GCGCGC-3′) was constructed using S primer OTR 998 (5′-G
CGCGCGCGATTAAAAGTGAAAGTAAACTC-3′) and AS primer
OTR 999 (5′-CACTTTTAATCGCGCGCGCGCGAACGCGTCGT
CTTCCTC-3′), generating mutant RCR004 (Fig. 2A).
In addition, two other mutants, RCR005 and RCR006 containing
heterologous trans-complementary sequence with a central “GC”
dyad were also created to determine if the pal nature of the sequence
is necessary for in vitro dimerization (Fig. 3A). The primers used for
RCR005 and RCR006 construction included OTR 1000 (S primer;
5′-ACGCACGCGATTAAAAGTGAAAGTAAACTC-3′) and OTR
1001 (AS; 5′-CAC TTT TAA TCG CGT GCG TGCGAACGCGTC
GTCTTCCTC-3′), OTR 1002 (S primer; 5′-GTGCGTGCGATT
AAAAGTGAAAGTAAACTC-3′) and OTR 1003 (AS primer; 5′-
CACTTTTAATCGCACGCACGCGAACGCGTCGTCTTCCTC-3′),
respectively. For all these mutants, the OTR 1004 (S) and OTR 1005
(AS) were used as outer primers during second round of amplifica-
tion, and the resulting amplified product containing the T7 promot-
er and the desired mutation was cleaved and cloned in pIC19R as
described above for creating wild-type clone RCR001. Both the
wild-type clone and all the pal mutant clones were confirmed by se-
quencing. PCRs were performed according to the method described
previously (Jaballah et al. 2010; Rizvi et al. 2010). Briefly, ∼3 μg of
template DNAwas used for each reaction under the following ampli-
fication conditions: denaturation for 2 min at 94°C followed by 30
cycles of 1min at 94°C, annealing at 45°C –47°C depending on prim-
ers used for 90 sec, and extension for 90 sec at 72°C. Final extension
was performed for 10min at 72°C followed by incubation at 4°C. The
precise details of the nucleotide locations of the primers and the in-
termediate cloning steps are available from us upon request.
RNA preparation by in vitro transcription
DNA templates containing the T7 RNA promoter at the 5′ end of the
MPMV sequences were linearized by digesting with the SmaI restric-
tion enzyme at the site present at the 3′ end of the MPMV sequence
in the RCR clone series (RCR001-RCR006). In vitro transcription
was performed using bacteriophage T7 RNA polymerase for 2 h at
37°C using conditions described previously (Marquet et al. 1991).
A small fraction of each sample was subjected to electrophoresis
on an 8% acrylamide/8 M urea gel to analyze the in vitro transcrip-
tion reaction products. The rest of the sample was treated with
DNase I for 30 min at 37°C and then extracted with phenol-chloro-
form and finally ethanol precipitated. The RNAswere purified by fast
protein liquid chromatography (FPLC; Pharmacia) on a TSK 250
column (Biorad) in a buffer containing 200 mM sodium acetate
(pH 6.5) and 1% (v/v)methanol. The desired fractions were concen-
trated in Amicon Ultra-4 10K centrifugal filter device (Millipore),
and the RNA concentrations were determined following quantifica-
tion through nanodrop (ThermoScientific). Finally, the RNAhomo-
geneity was checked by electrophoresis on an 8% acrylamide gel.
SHAPE methodology
To validate the predicted secondary structure of MPMV packaging
signal RNA sequence (Jaballah et al. 2010), the purified in vitro tran-
scribed RNAs were subjected to SHAPE (Mortimer and Weeks
2009) using benzoyl cyanide (BzCN). Briefly, 1 pmol of RNA in 8
μL milli-Q water (Millipore) was denatured for 2 min at 90°C and
then chilled for 2 min on ice, following which 2 μL 5X dimer buffer
(250 mM sodium cacodylate at pH 7.5; 1.5 M KCl; 25 mM MgCl2)
was added to the samples, which were then incubated for 20 min at
37°C. Next, 2 μg of total yeast tRNA (Sigma Aldrich) was added to
each sample, and the volume was adjusted to 15 μL by adding 1×
dimer buffer and incubated for 10 min at room temperature.
Three microliters of a 1 µM BzCN solution in anhydrous dimethyl
sulphoxide (DMSO) was used to modify the RNA samples for 1
min, and the reaction was stopped by adding 82 μL water. The neg-
ative control samples were treated in the same fashion but using only
DMSO in the absence of BzCN. All samples were then precipitated
using 1 μL of 1 μg/μL glycogen solution, 1/10 volume 3 M sodium
acetate (pH 6.5), and 3 volume ethanol for 30 min on dry ice, and
the precipitates were collected by centrifugation at 13,000g for 20
min at 4°C. The RNA pellets were washed two times with 500 μL
cold 80% ethanol to remove salts, dried in a vacuum dryer, and dis-
solved in 7 μL milli-Q water. Next, to identify the BzCN modifica-
tion sites, reverse transcription (RT) was performed on the samples.
Toward this end, two types of primer sequence were used to ensure
RT of the entire 550 nt MPMV leader RNA. A set of four AS primers
labeled with different dyes corresponded to the 5′-AGTTAC
TGGGACTTTCTCCG-3′ sequence (complementary to MPMV nt
483–502) and were termed as OTRs 17, 18, 19, and 20. A second
set of AS primers corresponded to the 5′-CTTACTTTCAGGTCC
AACGC-3′ sequence (complementary to MPMV nt 235–254), and
were named OTRs 21, 22, 23, and 24. These primers were labeled
with either 6-FAM, VIC, NED, or PET. The purpose of using differ-
ent dyes was that each dye could be detected individually after cap-
illary electrophoresis in a DNA sequencer according to the method
described earlier (Merino et al. 2005; Mortimer and Weeks 2007,
2009). BzCN-modified RNAs were annealed to 1 μM VIC-labeled
primers OTR 18 or OTR 22 for 2 min at 90°C and 2 min in ice.
After addition of 2 μL 5X RT buffer (Life Science), the samples
were then incubated for 10 min at room temperature. Each sample
was then divided into two aliquots, and elongation reaction was per-
formed for 30 min at 42°C and for 15 min at 50°C in elongation
buffer (1 μL 5× RT buffer, 3 μL 2.5 mM dNTPs mix, 1 μL 2 U/μL
RT AMV enzyme from Life Science and water to make the volume
to 10.5 μL). For the unmodified RNA samples, 6-FAM–labeled
primers OTR 17 or OTR 21 were used, and RT reaction was per-
formed in the same manner as for the modified RNA samples. A
ddA sequencing ladder was prepared using 2 pmol of untreated
RNA and 1 μL of 2 μM NED-labeled OTR 19 or OTR 23 in 8 µL
milliQ water. Annealing was performed by heating for 2 min at
90°C and cooling for 2 min on ice. The volume was made to 10
μL by adding 2 μL 10× RT buffer, and then the samples were incu-
bated for 15 min at room temperature. The RNA sample was ali-
quoted into two tubes, and the elongation reaction was performed
with 1 μL 10× RT buffer, 3 μL A10 (0.25 mM dATP, 1 mM
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dGTP, 1 mM dCTP, 1 mM dTTP), 1 μL of 100 μM ddA, and 1 μL of
1 units/μL RT AMV enzyme. A ddG ladder was also prepared in the
same fashion by using PET-labeled OTR 20 or OTR 24, G10 (0.25
mM dGTP, 1 mM dATP, 1 mM dCTP, 1 mM dTTP), and 100
μM ddG. All the reactions were stopped by adjusting the volume
45 μL with water, and proteins were extracted with 50 μL phenol-
chloroform. For each experiment, the modified and unmodified
samples were pooled with the corresponding ddA and ddG sequenc-
ing ladders (e.g., samples for which OTRs 17, 18, 19, and 20 were
used were pooled together) in a single tube containing 20 μL 3 M
sodium acetate and 600 μL ethanol for cDNA precipitation. The
samples were incubated on dry ice for 30 min, centrifuged at
13,000g for 20 min at 4°C, and washed twice with 1 mL cold 80%
ethanol. Pellets were spun for 5 min at each step to prevent material
loss. After drying the pellets in a vacuum dryer, they were resuspend-
ed in 10 μL HiDi formamide (ABI) and heat denatured at 90°C and
iced for 5 min each. The samples were spun down before loading on
the 96-well plates for sequencing on an Applied Biosystems 3130xl
genetic analyzer. The results were generated in the form of electro-
pherograms, which were analyzed with the SHAPEfinder program
(Vasa et al. 2008; Wilkinson et al. 2008) by following the steps pre-
scribed by program developers such as baseline adjustment, matrix-
ing, cubic mobility shift, signal decay correction, scale factor,
alignment and integration to MPMV sequence, and finally fitting.
This software enables the calculation of the SHAPE reactivity at
each nucleotide. Prior to performing the SHAPE reactions, we cal-
ibrated the fluorescent tagged primers for determining the mobility
shift (Vasa et al. 2008). The peaks in the electropherograms were
normalized by subtracting the peak area of the unmodified RNA
sample from the peak area of the SHAPE-treated sample (Vasa
et al. 2008). The data were then further normalized for outliers by
determining 10% of the highest values and excluding the highest
2% of these values. The remaining 8% of the values were averaged,
and the average value was used to divide the SHAPE data. The
SHAPE reactivity data (provided as supplemental data) obtained
for each nucleotide were then applied as constraints in the structure
prediction program RNAstructure (version 5.3) (Reuter and
Mathews 2010) in order to obtain the SHAPE-derived RNA struc-
ture of the MPMV packaging signal RNA.
In vitro dimerization assay
In vitro dimerization was performed according to the method de-
scribed previously (Marquet et al. 1991). Briefly, 300 nM of the pu-
rified wild-type or pal mutant RNAs was incubated in dimer (250
mM sodium cacodylate at pH 7.5; 1.5 M KCl; 25 mM MgCl2) or
monomer (250 mM sodium cacodylate at pH 7.5; 200 mM KCl;
0.5 mM MgCl2) buffer for 30 min at 37°C. Following this incuba-
tion, loading dye containing glycerol was added, and samples were
subjected to electrophoresis in native 1% TBM (50 mM Tris base,
45 mM boric acid, 0.1 mM MgCl2) or semi-denaturing TB (50
mMTris base, 45mMboric acid) Agarose gel at 4°C or 20°C, respec-
tively, stained with ethidium bromide and visualized for band shift
using ultraviolet (UV) transillumination. Band intensities were
measured using Quantity One software, and percentage (%) of
dimerization was calculated for eachmutant employing the formula:
(Intensity of dimer band – Intensity of background)/[(Intensity of
monomer band – Intensity of background) + (Intensity of dimer
band – Intensity of background)]. Results for each pal mutant
were plotted as relative dimerization to the wild-type values.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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